Grant - Venatorx Pharmaceuticals
Investment Firm
Overview
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Announced Date
Nov 25, 2019
Funding Type
Grant
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
 CARB-X |
Round Details and Background
Venatorx Pharmaceuticals raised $4100000 on 2019-11-25 in Grant
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Company Funding History
13
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 02, 2022 |  Venture Round - Venatorx Pharmaceuticals | - | 24.7M | |
| Jul 27, 2017 | Grant - Venatorx Pharmaceuticals | 1 | - | 9.4M |
| Jul 25, 2017 | Series B - Venatorx Pharmaceuticals | 4 | - | 42.0M |
| Nov 22, 2013 | Series A - Venatorx Pharmaceuticals | 1 | - | 3.4M |
Recent Activity
There is no recent news or activity for this profile.